

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 5.69706728 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.69706728 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.69706728 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.69706728 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.69706728 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.69706728 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 5.68965219 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.32923914 |
| 9 | detection of other organism (GO:0098543) | 5.13766845 |
| 10 | response to peptidoglycan (GO:0032494) | 4.92360269 |
| 11 | detection of molecule of bacterial origin (GO:0032490) | 4.81691104 |
| 12 | detection of bacterium (GO:0016045) | 4.79523824 |
| 13 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.75275120 |
| 14 | respiratory burst (GO:0045730) | 4.74050016 |
| 15 | detection of external biotic stimulus (GO:0098581) | 4.58173308 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.56730782 |
| 17 | granulocyte activation (GO:0036230) | 4.34794220 |
| 18 | neutrophil activation (GO:0042119) | 4.30688530 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 4.27213532 |
| 20 | positive regulation of mast cell degranulation (GO:0043306) | 4.27066153 |
| 21 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.27066153 |
| 22 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.21176779 |
| 23 | macrophage activation involved in immune response (GO:0002281) | 4.17907394 |
| 24 | positive regulation of interferon-alpha production (GO:0032727) | 4.15466989 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.14662458 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.08601346 |
| 27 | response to interleukin-15 (GO:0070672) | 4.08500295 |
| 28 | positive regulation of mast cell activation (GO:0033005) | 4.07206313 |
| 29 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.07152613 |
| 30 | detection of biotic stimulus (GO:0009595) | 3.99764232 |
| 31 | cellular extravasation (GO:0045123) | 3.93016465 |
| 32 | regulation of interferon-alpha production (GO:0032647) | 3.91798936 |
| 33 | positive regulation of antigen processing and presentation (GO:0002579) | 3.85859909 |
| 34 | regulation of mast cell degranulation (GO:0043304) | 3.84481760 |
| 35 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.81800386 |
| 36 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.80604093 |
| 37 | response to host immune response (GO:0052572) | 3.80604093 |
| 38 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.76957493 |
| 39 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.71439385 |
| 40 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.70193629 |
| 41 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.69019480 |
| 42 | cellular response to interleukin-15 (GO:0071350) | 3.68854636 |
| 43 | negative regulation of T cell mediated immunity (GO:0002710) | 3.68283688 |
| 44 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.67939156 |
| 45 | regulation of hypersensitivity (GO:0002883) | 3.65421226 |
| 46 | response to muramyl dipeptide (GO:0032495) | 3.62853900 |
| 47 | myeloid cell activation involved in immune response (GO:0002275) | 3.59182411 |
| 48 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.59025403 |
| 49 | myeloid dendritic cell differentiation (GO:0043011) | 3.57357109 |
| 50 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.55521333 |
| 51 | superoxide anion generation (GO:0042554) | 3.51202158 |
| 52 | positive regulation of leukocyte degranulation (GO:0043302) | 3.50599592 |
| 53 | regulation of T cell tolerance induction (GO:0002664) | 3.50525163 |
| 54 | B cell mediated immunity (GO:0019724) | 3.49772432 |
| 55 | germinal center formation (GO:0002467) | 3.49635759 |
| 56 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.48895331 |
| 57 | reactive oxygen species biosynthetic process (GO:1903409) | 3.45740489 |
| 58 | B cell receptor signaling pathway (GO:0050853) | 3.44925012 |
| 59 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.44558819 |
| 60 | regulation of mast cell activation (GO:0033003) | 3.43982179 |
| 61 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.43669841 |
| 62 | regulation of tolerance induction (GO:0002643) | 3.42165655 |
| 63 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.41337979 |
| 64 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.41337979 |
| 65 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.39736024 |
| 66 | myeloid dendritic cell activation (GO:0001773) | 3.38839805 |
| 67 | positive regulation of B cell differentiation (GO:0045579) | 3.37559008 |
| 68 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.34821830 |
| 69 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.33056656 |
| 70 | response to host (GO:0075136) | 3.32161402 |
| 71 | response to host defenses (GO:0052200) | 3.32161402 |
| 72 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.32161402 |
| 73 | natural killer cell mediated immunity (GO:0002228) | 3.31564765 |
| 74 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.31564765 |
| 75 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.31444781 |
| 76 | leukocyte aggregation (GO:0070486) | 3.29672210 |
| 77 | regulation of antigen processing and presentation (GO:0002577) | 3.29600307 |
| 78 | neutrophil mediated immunity (GO:0002446) | 3.27835575 |
| 79 | regulation of leukocyte degranulation (GO:0043300) | 3.26743462 |
| 80 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.26151063 |
| 81 | leukocyte mediated cytotoxicity (GO:0001909) | 3.21132041 |
| 82 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.20770321 |
| 83 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.20578956 |
| 84 | dendritic cell differentiation (GO:0097028) | 3.20447127 |
| 85 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.18065259 |
| 86 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.15090222 |
| 87 | dendritic cell chemotaxis (GO:0002407) | 3.14948658 |
| 88 | defense response to protozoan (GO:0042832) | 3.14786343 |
| 89 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.14640842 |
| 90 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.13611158 |
| 91 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.12847432 |
| 92 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.12788465 |
| 93 | dendritic cell migration (GO:0036336) | 3.12047647 |
| 94 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.11066425 |
| 95 | leukocyte degranulation (GO:0043299) | 3.11023537 |
| 96 | cellular response to zinc ion (GO:0071294) | 3.10425572 |
| 97 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.10032890 |
| 98 | myeloid leukocyte mediated immunity (GO:0002444) | 3.09658152 |
| 99 | response to type I interferon (GO:0034340) | 3.09022326 |
| 100 | negative regulation of interleukin-17 production (GO:0032700) | 3.08600532 |
| 101 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.06989982 |
| 102 | cellular response to type I interferon (GO:0071357) | 3.06139654 |
| 103 | type I interferon signaling pathway (GO:0060337) | 3.06139654 |
| 104 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.03891020 |
| 105 | negative thymic T cell selection (GO:0045060) | 3.02461315 |
| 106 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.01767683 |
| 107 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.00224898 |
| 108 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.00037427 |
| 109 | positive regulation of interferon-beta production (GO:0032728) | 2.99884715 |
| 110 | T-helper 1 type immune response (GO:0042088) | 2.97495590 |
| 111 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.97193490 |
| 112 | myeloid leukocyte activation (GO:0002274) | 2.96874822 |
| 113 | positive regulation of interleukin-12 production (GO:0032735) | 2.96366634 |
| 114 | NIK/NF-kappaB signaling (GO:0038061) | 2.96288462 |
| 115 | negative regulation of type 2 immune response (GO:0002829) | 2.96125841 |
| 116 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.95735820 |
| 117 | macrophage activation (GO:0042116) | 2.95363707 |
| 118 | regulation of B cell differentiation (GO:0045577) | 2.93401482 |
| 119 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.92062585 |
| 120 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.92062585 |
| 121 | negative T cell selection (GO:0043383) | 2.91530802 |
| 122 | microglial cell activation (GO:0001774) | 2.91366796 |
| 123 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.91043921 |
| 124 | regulation of mononuclear cell migration (GO:0071675) | 2.90831210 |
| 125 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.90408874 |
| 126 | response to protozoan (GO:0001562) | 2.89274141 |
| 127 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.88978832 |
| 128 | leukotriene metabolic process (GO:0006691) | 2.88416102 |
| 129 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.88405173 |
| 130 | T cell migration (GO:0072678) | 2.88051450 |
| 131 | negative regulation of cell killing (GO:0031342) | 2.86163143 |
| 132 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.86163143 |
| 133 | regulation of cholesterol storage (GO:0010885) | 2.85359550 |
| 134 | regulation of chemokine biosynthetic process (GO:0045073) | 2.85192818 |
| 135 | negative regulation of interleukin-12 production (GO:0032695) | 2.83953426 |
| 136 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.83059102 |
| 137 | neutrophil chemotaxis (GO:0030593) | 2.82311681 |
| 138 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.81762563 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.34402641 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.21073354 |
| 3 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.32604533 |
| 4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.14485102 |
| 5 | * BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.02690683 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.93001108 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.81922894 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.78452785 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.48884963 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.35684147 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.34361732 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.21925612 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.15096804 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.94085918 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.93820532 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.71684910 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.69993030 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.51473085 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.51288549 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.51249701 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.50461733 |
| 22 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.42422821 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 2.36897007 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.32362646 |
| 25 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17403397 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.11555594 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.11184910 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.10261205 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.03371252 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.01894630 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.93480748 |
| 32 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.91219234 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.90942059 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.88333633 |
| 35 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.78870655 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.76596591 |
| 37 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.75335178 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.67390483 |
| 39 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.67337027 |
| 40 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66108807 |
| 41 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64636421 |
| 42 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.63444833 |
| 43 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62412617 |
| 44 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.60728191 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.57266415 |
| 46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.55540170 |
| 47 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54060645 |
| 48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.50766429 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47631890 |
| 50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.45257969 |
| 51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45059985 |
| 52 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44368139 |
| 53 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41082853 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41061176 |
| 55 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38471281 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37961442 |
| 57 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35139783 |
| 58 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.34654359 |
| 59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32724673 |
| 60 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30966078 |
| 61 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29877151 |
| 62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27069920 |
| 63 | MYC_22102868_ChIP-Seq_BL_Human | 1.26544122 |
| 64 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.25409987 |
| 65 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24766616 |
| 66 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23870763 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22254007 |
| 68 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.21229242 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.17115445 |
| 70 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17056416 |
| 71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.15856278 |
| 72 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.15850523 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15655423 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15496147 |
| 75 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14779198 |
| 76 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.14248966 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13824968 |
| 78 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13385010 |
| 79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08981532 |
| 80 | MAF_26560356_Chip-Seq_TH2_Human | 1.07332998 |
| 81 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.02203487 |
| 82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00584142 |
| 83 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99007561 |
| 84 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97799472 |
| 85 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96695805 |
| 86 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95341651 |
| 87 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94205849 |
| 88 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92589592 |
| 89 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92177681 |
| 90 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91189845 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90486368 |
| 92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89517646 |
| 93 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.89485708 |
| 94 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88736475 |
| 95 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.87693554 |
| 96 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85572065 |
| 97 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85395344 |
| 98 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.84487021 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83623951 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.82072511 |
| 101 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80439124 |
| 102 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80130467 |
| 103 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76492597 |
| 104 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.75990364 |
| 105 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75384904 |
| 106 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.73427092 |
| 107 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.69451461 |
| 108 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.64956835 |
| 109 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62925434 |
| 110 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.62208924 |
| 111 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.61499490 |
| 112 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.61444294 |
| 113 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.60796327 |
| 114 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.60796327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.62678698 |
| 2 | MP0003303_peritoneal_inflammation | 4.00914465 |
| 3 | MP0003436_decreased_susceptibility_to | 3.95926241 |
| 4 | MP0009785_altered_susceptibility_to | 3.39097877 |
| 5 | * MP0002148_abnormal_hypersensitivity_rea | 3.37819357 |
| 6 | MP0002419_abnormal_innate_immunity | 3.27075299 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.11550648 |
| 8 | * MP0005025_abnormal_response_to | 2.88854839 |
| 9 | MP0006082_CNS_inflammation | 2.86005208 |
| 10 | MP0001790_abnormal_immune_system | 2.84376633 |
| 11 | MP0005387_immune_system_phenotype | 2.84376633 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.72354844 |
| 13 | MP0004510_myositis | 2.71449648 |
| 14 | MP0000685_abnormal_immune_system | 2.66628764 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.65777157 |
| 16 | MP0005671_abnormal_response_to | 2.60972270 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.49434659 |
| 18 | * MP0001800_abnormal_humoral_immune | 2.48841698 |
| 19 | * MP0002723_abnormal_immune_serum | 2.47436402 |
| 20 | MP0003724_increased_susceptibility_to | 2.43982893 |
| 21 | * MP0001819_abnormal_immune_cell | 2.32360995 |
| 22 | * MP0002420_abnormal_adaptive_immunity | 2.29755751 |
| 23 | MP0005310_abnormal_salivary_gland | 2.11486869 |
| 24 | MP0001533_abnormal_skeleton_physiology | 1.99633500 |
| 25 | MP0001853_heart_inflammation | 1.98286932 |
| 26 | * MP0002405_respiratory_system_inflammati | 1.97127153 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.90313007 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.86200415 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.82055946 |
| 30 | MP0005451_abnormal_body_composition | 1.82022171 |
| 31 | MP0004947_skin_inflammation | 1.81389093 |
| 32 | MP0009764_decreased_sensitivity_to | 1.81215526 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.75435826 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.72909651 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.72909651 |
| 36 | MP0003448_altered_tumor_morphology | 1.72648822 |
| 37 | MP0002398_abnormal_bone_marrow | 1.72395347 |
| 38 | * MP0000716_abnormal_immune_system | 1.69698121 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.67598226 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.66698552 |
| 41 | MP0009278_abnormal_bone_marrow | 1.66615661 |
| 42 | MP0008469_abnormal_protein_level | 1.61269392 |
| 43 | MP0000343_altered_response_to | 1.60794708 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.53244997 |
| 45 | MP0002006_tumorigenesis | 1.52610350 |
| 46 | MP0010307_abnormal_tumor_latency | 1.45822233 |
| 47 | MP0003075_altered_response_to | 1.45679443 |
| 48 | MP0000858_altered_metastatic_potential | 1.42129814 |
| 49 | * MP0002429_abnormal_blood_cell | 1.41876231 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.41734931 |
| 51 | MP0009840_abnormal_foam_cell | 1.40489924 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.39889934 |
| 53 | MP0000569_abnormal_digit_pigmentation | 1.38494460 |
| 54 | * MP0002722_abnormal_immune_system | 1.33627195 |
| 55 | MP0004381_abnormal_hair_follicle | 1.30078504 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.27600606 |
| 57 | MP0002166_altered_tumor_susceptibility | 1.26058401 |
| 58 | MP0002254_reproductive_system_inflammat | 1.25641299 |
| 59 | MP0001851_eye_inflammation | 1.23424183 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.21810151 |
| 61 | MP0000604_amyloidosis | 1.20810867 |
| 62 | MP0004808_abnormal_hematopoietic_stem | 1.18142945 |
| 63 | MP0005166_decreased_susceptibility_to | 1.17853468 |
| 64 | MP0005174_abnormal_tail_pigmentation | 1.16569178 |
| 65 | MP0003828_pulmonary_edema | 1.10418950 |
| 66 | MP0003566_abnormal_cell_adhesion | 1.04631453 |
| 67 | MP0010352_gastrointestinal_tract_polyps | 1.03589118 |
| 68 | MP0005076_abnormal_cell_differentiation | 1.02013340 |
| 69 | MP0009763_increased_sensitivity_to | 1.00268161 |
| 70 | MP0003183_abnormal_peptide_metabolism | 0.99727023 |
| 71 | MP0003690_abnormal_glial_cell | 0.95556366 |
| 72 | MP0008004_abnormal_stomach_pH | 0.94870335 |
| 73 | MP0003186_abnormal_redox_activity | 0.92643400 |
| 74 | MP0000490_abnormal_crypts_of | 0.92306718 |
| 75 | MP0002877_abnormal_melanocyte_morpholog | 0.91965621 |
| 76 | MP0005390_skeleton_phenotype | 0.87669667 |
| 77 | MP0001873_stomach_inflammation | 0.87518680 |
| 78 | MP0005164_abnormal_response_to | 0.87118384 |
| 79 | MP0004782_abnormal_surfactant_physiolog | 0.86863287 |
| 80 | MP0002277_abnormal_respiratory_mucosa | 0.85644655 |
| 81 | MP0002396_abnormal_hematopoietic_system | 0.85446714 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 0.84380418 |
| 83 | MP0003763_abnormal_thymus_physiology | 0.81159596 |
| 84 | MP0008260_abnormal_autophagy | 0.80849032 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 0.80503929 |
| 86 | MP0002933_joint_inflammation | 0.79659011 |
| 87 | MP0003866_abnormal_defecation | 0.77324076 |
| 88 | MP0003045_fibrosis | 0.77000439 |
| 89 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76476811 |
| 90 | MP0005257_abnormal_intraocular_pressure | 0.74081780 |
| 91 | MP0000371_diluted_coat_color | 0.73727180 |
| 92 | MP0000249_abnormal_blood_vessel | 0.73657011 |
| 93 | MP0001348_abnormal_lacrimal_gland | 0.69699369 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 0.69479543 |
| 95 | MP0008874_decreased_physiological_sensi | 0.67731564 |
| 96 | MP0000703_abnormal_thymus_morphology | 0.67044826 |
| 97 | MP0003795_abnormal_bone_structure | 0.66035530 |
| 98 | MP0000015_abnormal_ear_pigmentation | 0.65438609 |
| 99 | MP0001663_abnormal_digestive_system | 0.63959762 |
| 100 | MP0003806_abnormal_nucleotide_metabolis | 0.62000042 |
| 101 | MP0002332_abnormal_exercise_endurance | 0.59312725 |
| 102 | MP0002132_abnormal_respiratory_system | 0.59252080 |
| 103 | MP0008873_increased_physiological_sensi | 0.58441931 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.58389266 |
| 105 | MP0004130_abnormal_muscle_cell | 0.54779701 |
| 106 | MP0001986_abnormal_taste_sensitivity | 0.53911710 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.53692832 |
| 108 | MP0002133_abnormal_respiratory_system | 0.52909039 |
| 109 | MP0005388_respiratory_system_phenotype | 0.52909039 |
| 110 | MP0004883_abnormal_blood_vessel | 0.52335677 |
| 111 | MP0005319_abnormal_enzyme/_coenzyme | 0.51951340 |
| 112 | MP0002019_abnormal_tumor_incidence | 0.51897931 |
| 113 | MP0003091_abnormal_cell_migration | 0.51873865 |
| 114 | MP0000920_abnormal_myelination | 0.50494710 |
| 115 | MP0001958_emphysema | 0.48543634 |
| 116 | MP0000609_abnormal_liver_physiology | 0.47972235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.52608812 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.19127062 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 7.03910380 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.30115320 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.24911445 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 4.93155948 |
| 7 | Recurrent skin infections (HP:0001581) | 4.48866345 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 4.44143948 |
| 9 | Recurrent fungal infections (HP:0002841) | 4.32689504 |
| 10 | Obstructive lung disease (HP:0006536) | 4.25424027 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 4.25424027 |
| 12 | Petechiae (HP:0000967) | 4.24837387 |
| 13 | Gingivitis (HP:0000230) | 4.14557068 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 4.13390852 |
| 15 | Myositis (HP:0100614) | 3.87481397 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.78627614 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.75325400 |
| 18 | Encephalitis (HP:0002383) | 3.74222486 |
| 19 | Autoimmune thrombocytopenia (HP:0001973) | 3.69693748 |
| 20 | Stomatitis (HP:0010280) | 3.62111180 |
| 21 | Cellulitis (HP:0100658) | 3.61696769 |
| 22 | Orchitis (HP:0100796) | 3.59498923 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 3.59271858 |
| 24 | Recurrent viral infections (HP:0004429) | 3.51441734 |
| 25 | Optic neuritis (HP:0100653) | 3.38051797 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.38051797 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.35285494 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.35285494 |
| 29 | Vasculitis (HP:0002633) | 3.25698201 |
| 30 | Tetraparesis (HP:0002273) | 3.15134433 |
| 31 | Urticaria (HP:0001025) | 3.12341603 |
| 32 | Periodontitis (HP:0000704) | 3.10508757 |
| 33 | T lymphocytopenia (HP:0005403) | 3.07363271 |
| 34 | Axonal loss (HP:0003447) | 3.04638204 |
| 35 | Hypochromic microcytic anemia (HP:0004840) | 3.00493533 |
| 36 | Peritonitis (HP:0002586) | 2.98851589 |
| 37 | Abnormality of T cell number (HP:0011839) | 2.98051221 |
| 38 | Episodic fever (HP:0001954) | 2.96714151 |
| 39 | Meningitis (HP:0001287) | 2.95966772 |
| 40 | Interstitial pulmonary disease (HP:0006530) | 2.95828989 |
| 41 | Chronic otitis media (HP:0000389) | 2.94110596 |
| 42 | Disinhibition (HP:0000734) | 2.93730821 |
| 43 | Gingival bleeding (HP:0000225) | 2.93703392 |
| 44 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.91294190 |
| 45 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.91294190 |
| 46 | Abnormality of glycolipid metabolism (HP:0010969) | 2.91294190 |
| 47 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.90311520 |
| 48 | Pustule (HP:0200039) | 2.88240800 |
| 49 | Dysostosis multiplex (HP:0000943) | 2.87358812 |
| 50 | Prostate neoplasm (HP:0100787) | 2.86749523 |
| 51 | Prolonged bleeding time (HP:0003010) | 2.82605859 |
| 52 | Hypochromic anemia (HP:0001931) | 2.79975182 |
| 53 | Pulmonary embolism (HP:0002204) | 2.72802795 |
| 54 | Leukocytosis (HP:0001974) | 2.72713564 |
| 55 | Anorexia (HP:0002039) | 2.71832287 |
| 56 | Myocardial infarction (HP:0001658) | 2.70378405 |
| 57 | Amyloidosis (HP:0011034) | 2.68724059 |
| 58 | Basal ganglia calcification (HP:0002135) | 2.68414826 |
| 59 | Osteomyelitis (HP:0002754) | 2.66882589 |
| 60 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.61884886 |
| 61 | Pulmonary infiltrates (HP:0002113) | 2.61192213 |
| 62 | Increased IgM level (HP:0003496) | 2.60592164 |
| 63 | Abnormality of T cells (HP:0002843) | 2.56549487 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.55804766 |
| 65 | Panhypogammaglobulinemia (HP:0003139) | 2.52734697 |
| 66 | Epistaxis (HP:0000421) | 2.52703343 |
| 67 | Arterial thrombosis (HP:0004420) | 2.51375016 |
| 68 | Recurrent pneumonia (HP:0006532) | 2.49790439 |
| 69 | Thick nail (HP:0001805) | 2.49046268 |
| 70 | Purpura (HP:0000979) | 2.47531340 |
| 71 | Gastrointestinal infarctions (HP:0005244) | 2.47372065 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.45267648 |
| 73 | Gangrene (HP:0100758) | 2.42877025 |
| 74 | Granulocytopenia (HP:0001913) | 2.42534990 |
| 75 | Abnormality of the peritoneum (HP:0002585) | 2.41312575 |
| 76 | Impaired platelet aggregation (HP:0003540) | 2.39635258 |
| 77 | Abnormal platelet function (HP:0011869) | 2.39635258 |
| 78 | Abnormality of the pleura (HP:0002103) | 2.39515065 |
| 79 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.39353452 |
| 80 | Mucopolysacchariduria (HP:0008155) | 2.39353452 |
| 81 | Agnosia (HP:0010524) | 2.36329853 |
| 82 | Hemoptysis (HP:0002105) | 2.35130897 |
| 83 | Loss of speech (HP:0002371) | 2.26490338 |
| 84 | Glomerulonephritis (HP:0000099) | 2.26295659 |
| 85 | Hypergammaglobulinemia (HP:0010702) | 2.24820786 |
| 86 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.23829016 |
| 87 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.23829016 |
| 88 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.23829016 |
| 89 | Microcytic anemia (HP:0001935) | 2.23484464 |
| 90 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.22336709 |
| 91 | Recurrent lower respiratory tract infections (HP:0002783) | 2.21206218 |
| 92 | Abnormality of the endocardium (HP:0004306) | 2.20214674 |
| 93 | Hematochezia (HP:0002573) | 2.19904971 |
| 94 | Lymphopenia (HP:0001888) | 2.18100693 |
| 95 | Abnormality of T cell physiology (HP:0011840) | 2.17939650 |
| 96 | Thrombocytosis (HP:0001894) | 2.17731153 |
| 97 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.16554413 |
| 98 | Glomerulopathy (HP:0100820) | 2.13960438 |
| 99 | Joint hemorrhage (HP:0005261) | 2.12629687 |
| 100 | Viral hepatitis (HP:0006562) | 2.12460949 |
| 101 | Premature loss of primary teeth (HP:0006323) | 2.11771094 |
| 102 | Inflammation of the large intestine (HP:0002037) | 2.10646195 |
| 103 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.10304950 |
| 104 | Abnormality of the prostate (HP:0008775) | 2.10095101 |
| 105 | Increased IgE level (HP:0003212) | 2.08385095 |
| 106 | Abnormal platelet volume (HP:0011876) | 2.08015880 |
| 107 | Slow saccadic eye movements (HP:0000514) | 2.07832334 |
| 108 | Sepsis (HP:0100806) | 2.07716009 |
| 109 | Vertigo (HP:0002321) | 2.07235456 |
| 110 | Hepatosplenomegaly (HP:0001433) | 2.06978730 |
| 111 | Colitis (HP:0002583) | 2.06520030 |
| 112 | Nasal polyposis (HP:0100582) | 2.05874358 |
| 113 | Chest pain (HP:0100749) | 2.04369237 |
| 114 | Keratoconjunctivitis sicca (HP:0001097) | 2.02514875 |
| 115 | Menorrhagia (HP:0000132) | 2.01925308 |
| 116 | Keratitis (HP:0000491) | 1.98907150 |
| 117 | Acne (HP:0001061) | 1.98450852 |
| 118 | Osteolytic defects of the hand bones (HP:0009699) | 1.96871830 |
| 119 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.96871830 |
| 120 | IgM deficiency (HP:0002850) | 1.96860289 |
| 121 | Gastrointestinal inflammation (HP:0004386) | 1.96344484 |
| 122 | Agammaglobulinemia (HP:0004432) | 1.95926055 |
| 123 | Eosinophilia (HP:0001880) | 1.95618311 |
| 124 | Acute hepatic failure (HP:0006554) | 1.95371759 |
| 125 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.93815240 |
| 126 | Bone pain (HP:0002653) | 1.91536134 |
| 127 | Increased serum ferritin (HP:0003281) | 1.90757541 |
| 128 | Keratoconjunctivitis (HP:0001096) | 1.90112207 |
| 129 | Polycythemia (HP:0001901) | 1.89925099 |
| 130 | Skin rash (HP:0000988) | 1.89301542 |
| 131 | Recurrent bronchitis (HP:0002837) | 1.88962862 |
| 132 | Abnormality of the nasal mucosa (HP:0000433) | 1.88918602 |
| 133 | Skin ulcer (HP:0200042) | 1.88829662 |
| 134 | Poor head control (HP:0002421) | 1.88749476 |
| 135 | Albinism (HP:0001022) | 1.88274326 |
| 136 | Subacute progressive viral hepatitis (HP:0006572) | 1.87731408 |
| 137 | Abnormality of the pericardium (HP:0001697) | 1.87721876 |
| 138 | J-shaped sella turcica (HP:0002680) | 1.87083259 |
| 139 | Cheilitis (HP:0100825) | 1.86233111 |
| 140 | Polyneuropathy (HP:0001271) | 1.85544065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.54077730 |
| 2 | BLK | 3.96618483 |
| 3 | MAP3K14 | 3.84614575 |
| 4 | MAP4K1 | 3.22600442 |
| 5 | TBK1 | 3.20392151 |
| 6 | IRAK4 | 3.20285401 |
| 7 | TYK2 | 2.96306006 |
| 8 | IRAK3 | 2.90312410 |
| 9 | PIM2 | 2.66722422 |
| 10 | IKBKB | 2.46933634 |
| 11 | PRPF4B | 2.44338864 |
| 12 | TAOK3 | 2.40925125 |
| 13 | KIT | 2.20501886 |
| 14 | JAK3 | 2.19944981 |
| 15 | IKBKE | 2.18851448 |
| 16 | TNK2 | 2.01413626 |
| 17 | PBK | 1.97828851 |
| 18 | ERN1 | 1.93424835 |
| 19 | JAK1 | 1.76019265 |
| 20 | TAOK1 | 1.74312932 |
| 21 | SYK | 1.65144600 |
| 22 | TXK | 1.59730166 |
| 23 | NEK9 | 1.56561070 |
| 24 | BTK | 1.55482788 |
| 25 | ZAP70 | 1.53196294 |
| 26 | PIM1 | 1.51559856 |
| 27 | CHUK | 1.51538264 |
| 28 | EPHB1 | 1.49737849 |
| 29 | CSK | 1.46271357 |
| 30 | BMX | 1.44366261 |
| 31 | HCK | 1.37851232 |
| 32 | KSR2 | 1.34136243 |
| 33 | MAP3K13 | 1.33839041 |
| 34 | CSF1R | 1.33117984 |
| 35 | TRIB3 | 1.27992301 |
| 36 | FES | 1.27479923 |
| 37 | TEC | 1.22910245 |
| 38 | STK4 | 1.17261713 |
| 39 | RPS6KA4 | 1.12351091 |
| 40 | STK10 | 1.11989990 |
| 41 | * LYN | 1.04853891 |
| 42 | FGR | 1.04364491 |
| 43 | NME2 | 1.02922501 |
| 44 | CLK1 | 1.02920446 |
| 45 | MATK | 1.01964680 |
| 46 | LCK | 1.01802389 |
| 47 | MAP2K3 | 1.01132132 |
| 48 | ABL2 | 1.01005692 |
| 49 | MARK2 | 0.98967891 |
| 50 | IRAK2 | 0.97675267 |
| 51 | TGFBR2 | 0.92375915 |
| 52 | * JAK2 | 0.91891157 |
| 53 | TAOK2 | 0.89765240 |
| 54 | MST4 | 0.88607353 |
| 55 | CDK6 | 0.85359666 |
| 56 | MAP3K11 | 0.84345429 |
| 57 | TRPM7 | 0.83049703 |
| 58 | MAP3K6 | 0.82450833 |
| 59 | EIF2AK1 | 0.81757236 |
| 60 | MARK3 | 0.80167175 |
| 61 | LRRK2 | 0.78888303 |
| 62 | SMG1 | 0.78396833 |
| 63 | YES1 | 0.77652524 |
| 64 | PRKD2 | 0.77499662 |
| 65 | PKN2 | 0.76229248 |
| 66 | FGFR3 | 0.76073374 |
| 67 | MAP3K2 | 0.74013818 |
| 68 | SCYL2 | 0.71591211 |
| 69 | CDC42BPA | 0.71082695 |
| 70 | BMPR2 | 0.69636400 |
| 71 | TESK2 | 0.68479034 |
| 72 | SIK2 | 0.67077934 |
| 73 | CDK19 | 0.66984842 |
| 74 | ABL1 | 0.65592923 |
| 75 | ITK | 0.64123194 |
| 76 | FYN | 0.63966019 |
| 77 | PRKCD | 0.63095081 |
| 78 | MAP3K5 | 0.62897613 |
| 79 | MAP3K7 | 0.61753892 |
| 80 | MAP2K4 | 0.61235641 |
| 81 | PTK6 | 0.60348299 |
| 82 | EGFR | 0.59639582 |
| 83 | PTK2B | 0.58531915 |
| 84 | MAPK12 | 0.58414192 |
| 85 | GRK6 | 0.55626695 |
| 86 | SGK3 | 0.55255891 |
| 87 | HIPK2 | 0.54398534 |
| 88 | MAPKAPK2 | 0.54295207 |
| 89 | RAF1 | 0.53348923 |
| 90 | STK3 | 0.52281116 |
| 91 | STK11 | 0.51740601 |
| 92 | RPS6KA6 | 0.51653176 |
| 93 | EPHA3 | 0.51044983 |
| 94 | RIPK1 | 0.50700734 |
| 95 | FLT3 | 0.50273593 |
| 96 | MAPK7 | 0.50058931 |
| 97 | DYRK1B | 0.49079974 |
| 98 | SIK3 | 0.48920705 |
| 99 | DAPK2 | 0.47506770 |
| 100 | MAP3K10 | 0.47454274 |
| 101 | FGFR4 | 0.46742250 |
| 102 | RET | 0.45924537 |
| 103 | PRKCQ | 0.45576898 |
| 104 | TESK1 | 0.45382165 |
| 105 | ALK | 0.44072666 |
| 106 | PIK3CG | 0.43604818 |
| 107 | KSR1 | 0.42671685 |
| 108 | EIF2AK2 | 0.42326783 |
| 109 | NLK | 0.41557016 |
| 110 | RPS6KA2 | 0.41192030 |
| 111 | CDK12 | 0.41084504 |
| 112 | GRK7 | 0.40532002 |
| 113 | MAP2K6 | 0.37895438 |
| 114 | RPS6KC1 | 0.37559866 |
| 115 | RPS6KL1 | 0.37559866 |
| 116 | CAMK1D | 0.37106130 |
| 117 | IRAK1 | 0.36792063 |
| 118 | SGK2 | 0.36652863 |
| 119 | PRKG2 | 0.34894047 |
| 120 | CAMKK1 | 0.33802340 |
| 121 | MST1R | 0.33653554 |
| 122 | SIK1 | 0.33099615 |
| 123 | WNK1 | 0.33027682 |
| 124 | MAP3K1 | 0.32628268 |
| 125 | PDK1 | 0.32061259 |
| 126 | PDPK1 | 0.31271446 |
| 127 | STK24 | 0.31028691 |
| 128 | STK38 | 0.31022888 |
| 129 | MAP3K3 | 0.30498734 |
| 130 | PAK4 | 0.29909068 |
| 131 | CAMKK2 | 0.29301126 |
| 132 | MAP3K12 | 0.29069085 |
| 133 | TTN | 0.29039325 |
| 134 | DAPK3 | 0.28669405 |
| 135 | KDR | 0.27380443 |
| 136 | RPS6KA1 | 0.27149480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.60395622 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.74080376 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.68539885 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.67221228 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.57046602 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.47573200 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.47380267 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.41994066 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.37297372 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 2.25554924 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.21710271 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.19267968 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.15361633 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.10990977 |
| 15 | Measles_Homo sapiens_hsa05162 | 2.06813401 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 2.02582595 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.95331584 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.92031898 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.90377985 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.84449408 |
| 21 | Phagosome_Homo sapiens_hsa04145 | 1.84186393 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.81843523 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.78636038 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.73231556 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.72194250 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.68602504 |
| 27 | Salmonella infection_Homo sapiens_hsa05132 | 1.66412151 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.63449734 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.53317525 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.52139687 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.51695547 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.50330437 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46795658 |
| 34 | * Apoptosis_Homo sapiens_hsa04210 | 1.45358750 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.43845992 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.41701408 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.38994891 |
| 38 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.37533236 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.35942864 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.34232021 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.30689277 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.20298668 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.18815385 |
| 44 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18076705 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10985806 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09546845 |
| 47 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09211783 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.07902640 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02169599 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.99753398 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.97457982 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97046149 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95832029 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.93855732 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.90946121 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89245098 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.89018721 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86374732 |
| 59 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.84452949 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80789156 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78158782 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77398456 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77322351 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76768468 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75506680 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66969301 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65791733 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65236827 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64249227 |
| 70 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62596752 |
| 71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62044569 |
| 72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60794149 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57520175 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57247921 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55573233 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55033168 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53953994 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53817047 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53750562 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51098490 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50303770 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49808264 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48109696 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47804056 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47281204 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46912536 |
| 87 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46865967 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45049687 |
| 89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43260883 |
| 90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43020535 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.42379716 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41794408 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.41541607 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41521874 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40831331 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40323827 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.37933572 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36785080 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36565165 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36511267 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.36502709 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35152307 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29283542 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.27831057 |
| 105 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.25277455 |
| 106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25258139 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24708744 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21388092 |
| 109 | ABC transporters_Homo sapiens_hsa02010 | 0.19320698 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.19032365 |
| 111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.19028825 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.18298348 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.18196080 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.17456939 |
| 115 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.16094658 |
| 116 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.15754641 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.15123121 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.14500194 |

